Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,191
archived clinical trials in
Constipation

Alvimopan For The Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate the Efficacy and Safety of Alvimopan 0.5mg Once Daily and 0.5mg Twice Daily for 12 Weeks for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain
Status: Enrolling
Updated:  9/1/2015
GSK Investigational Site
874
mi
from 91732
Yakima, WA
Alvimopan For The Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate the Efficacy and Safety of Alvimopan 0.5mg Once Daily and 0.5mg Twice Daily for 12 Weeks for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain
Status: Enrolling
Updated: 9/1/2015
GSK Investigational Site
874
mi
from 91732
Yakima, WA
Click here to add this to my saved trials
Alvimopan For The Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate the Efficacy and Safety of Alvimopan 0.5mg Once Daily and 0.5mg Twice Daily for 12 Weeks for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain
Status: Enrolling
Updated:  9/1/2015
GSK Investigational Site
2036
mi
from 91732
Charleston, WV
Alvimopan For The Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate the Efficacy and Safety of Alvimopan 0.5mg Once Daily and 0.5mg Twice Daily for 12 Weeks for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain
Status: Enrolling
Updated: 9/1/2015
GSK Investigational Site
2036
mi
from 91732
Charleston, WV
Click here to add this to my saved trials
Alvimopan For The Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate the Efficacy and Safety of Alvimopan 0.5mg Once Daily and 0.5mg Twice Daily for 12 Weeks for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain
Status: Enrolling
Updated:  9/1/2015
GSK Investigational Site
1579
mi
from 91732
La Crosse, WI
Alvimopan For The Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate the Efficacy and Safety of Alvimopan 0.5mg Once Daily and 0.5mg Twice Daily for 12 Weeks for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain
Status: Enrolling
Updated: 9/1/2015
GSK Investigational Site
1579
mi
from 91732
La Crosse, WI
Click here to add this to my saved trials
Alvimopan For The Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate the Efficacy and Safety of Alvimopan 0.5mg Once Daily and 0.5mg Twice Daily for 12 Weeks for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain
Status: Enrolling
Updated:  9/1/2015
GSK Investigational Site
7455
mi
from 91732
Broadmeadow,
Alvimopan For The Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate the Efficacy and Safety of Alvimopan 0.5mg Once Daily and 0.5mg Twice Daily for 12 Weeks for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain
Status: Enrolling
Updated: 9/1/2015
GSK Investigational Site
7455
mi
from 91732
Broadmeadow,
Click here to add this to my saved trials
Effect of Lidocaine and Esmolol to Improve the Quality of Recovery
Effect of Lidocaine and Esmolol Alone or in Combination to Improve the Quality of Recovery, Maintaining Hemodynamic Stability During Abdominal Surgery
Status: Enrolling
Updated:  9/3/2015
Cedars-Sinai Medical Center
13
mi
from 91732
Los Angeles, CA
Effect of Lidocaine and Esmolol to Improve the Quality of Recovery
Effect of Lidocaine and Esmolol Alone or in Combination to Improve the Quality of Recovery, Maintaining Hemodynamic Stability During Abdominal Surgery
Status: Enrolling
Updated: 9/3/2015
Cedars-Sinai Medical Center
13
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
Alabama Clinical Therapeutics, Llc
1792
mi
from 91732
Birmingham, AL
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
Alabama Clinical Therapeutics, Llc
1792
mi
from 91732
Birmingham, AL
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
G&L Research, LLC
1783
mi
from 91732
Foley, AL
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
G&L Research, LLC
1783
mi
from 91732
Foley, AL
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
Adobe Gastroenterology Research, LLC
429
mi
from 91732
Tucson, AZ
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
Adobe Gastroenterology Research, LLC
429
mi
from 91732
Tucson, AZ
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
Skyline Research LLC
15
mi
from 91732
Cerritos, CA
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
Skyline Research LLC
15
mi
from 91732
Cerritos, CA
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
GW Research Inc,
113
mi
from 91732
Chula Vista, CA
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
GW Research Inc,
113
mi
from 91732
Chula Vista, CA
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
Paradigm Clinical, Inc.
21
mi
from 91732
Garden Grove, CA
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
Paradigm Clinical, Inc.
21
mi
from 91732
Garden Grove, CA
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
Providence Clinical Research
22
mi
from 91732
North Hollywood, CA
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
Providence Clinical Research
22
mi
from 91732
North Hollywood, CA
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
Stamford Therapeutics Consortium
2455
mi
from 91732
Stamford, CT
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
Stamford Therapeutics Consortium
2455
mi
from 91732
Stamford, CT
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
Pulmonary Associates Of Brandon
2146
mi
from 91732
Brandon, FL
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
Pulmonary Associates Of Brandon
2146
mi
from 91732
Brandon, FL
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
In Vivo Clinical Research, Inc.
2314
mi
from 91732
Hialeah, FL
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
In Vivo Clinical Research, Inc.
2314
mi
from 91732
Hialeah, FL
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
Medsearch Professional Group, Inc.
2314
mi
from 91732
Hialeah, FL
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
Medsearch Professional Group, Inc.
2314
mi
from 91732
Hialeah, FL
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
The Community Research Of South Florida
2315
mi
from 91732
Hialeah, FL
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
The Community Research Of South Florida
2315
mi
from 91732
Hialeah, FL
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
Center for Gastrointestinal Disorders
2315
mi
from 91732
Hollywood, FL
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
Center for Gastrointestinal Disorders
2315
mi
from 91732
Hollywood, FL
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
Nature Coast Clinical Research
2122
mi
from 91732
Inverness, FL
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
Nature Coast Clinical Research
2122
mi
from 91732
Inverness, FL
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
Gastroenterology and Hepatology Associates
2130
mi
from 91732
Jacksonville, FL
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
Gastroenterology and Hepatology Associates
2130
mi
from 91732
Jacksonville, FL
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
Jupiter Research
2296
mi
from 91732
Jupiter, FL
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
Jupiter Research
2296
mi
from 91732
Jupiter, FL
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
Center for Advanced Gastroenterology
2182
mi
from 91732
Maitland, FL
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
Center for Advanced Gastroenterology
2182
mi
from 91732
Maitland, FL
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
Advanced Pharma CR, LLC
2310
mi
from 91732
Miami, FL
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
Advanced Pharma CR, LLC
2310
mi
from 91732
Miami, FL
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
Research Institute of South Florida
2314
mi
from 91732
Miami, FL
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
Research Institute of South Florida
2314
mi
from 91732
Miami, FL
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
Gastroenterology Group of Naples
2220
mi
from 91732
Naples, FL
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
Gastroenterology Group of Naples
2220
mi
from 91732
Naples, FL
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
Palm Beach Research Center
2302
mi
from 91732
West Palm Beach, FL
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
Palm Beach Research Center
2302
mi
from 91732
West Palm Beach, FL
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
Georgia Clinical Research, LLC
1939
mi
from 91732
Snellville, GA
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
Georgia Clinical Research, LLC
1939
mi
from 91732
Snellville, GA
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
Elite Clinical Trials, Inc.
699
mi
from 91732
Blackfoot, ID
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
Elite Clinical Trials, Inc.
699
mi
from 91732
Blackfoot, ID
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
Medisphere Medical Research Center
1717
mi
from 91732
Evansville, IN
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
Medisphere Medical Research Center
1717
mi
from 91732
Evansville, IN
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
MidAtlantic Medical Research Centers, Philip J. Bean Medical Center
2309
mi
from 91732
Hollywood, MD
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
MidAtlantic Medical Research Centers, Philip J. Bean Medical Center
2309
mi
from 91732
Hollywood, MD
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
Boston Clinical Trials, INC.
2578
mi
from 91732
Boston, MA
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
Boston Clinical Trials, INC.
2578
mi
from 91732
Boston, MA
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
University of Michigan Health System
1932
mi
from 91732
Ann Arbor, MI
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
University of Michigan Health System
1932
mi
from 91732
Ann Arbor, MI
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
Midwest Gastroenterology Partners
mi
from 91732
Lee's Summit, MO
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
Midwest Gastroenterology Partners
mi
from 91732
Lee's Summit, MO
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
Advanced Biomedical Research of America
212
mi
from 91732
Las Vegas, NV
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
Advanced Biomedical Research of America
212
mi
from 91732
Las Vegas, NV
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
ActivMed Practices & Research
2588
mi
from 91732
Newington, NH
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
ActivMed Practices & Research
2588
mi
from 91732
Newington, NH
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
HOSC, Inc.
mi
from 91732
Brooklyn, NY
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
HOSC, Inc.
mi
from 91732
Brooklyn, NY
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
North American Partners in Pain Management
2448
mi
from 91732
Valley Stream, NY
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
North American Partners in Pain Management
2448
mi
from 91732
Valley Stream, NY
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
Carolina Digestive Health Associates
2100
mi
from 91732
Davidson, NC
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
Carolina Digestive Health Associates
2100
mi
from 91732
Davidson, NC
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
Cumberland Research Associates
2208
mi
from 91732
Fayetteville, NC
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
Cumberland Research Associates
2208
mi
from 91732
Fayetteville, NC
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
Gastroenterology Research Consultants of Greater Cincinnati
1887
mi
from 91732
Cincinnati, OH
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
Gastroenterology Research Consultants of Greater Cincinnati
1887
mi
from 91732
Cincinnati, OH
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
Hometown Urgent Care and Occupational Health
1966
mi
from 91732
Groveport, OH
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
Hometown Urgent Care and Occupational Health
1966
mi
from 91732
Groveport, OH
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
Oklahoma Foundation for Digestive Research
1165
mi
from 91732
Oklahoma City, OK
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
Oklahoma Foundation for Digestive Research
1165
mi
from 91732
Oklahoma City, OK
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
Clinical Trials Research Services, LLC
2123
mi
from 91732
Pittsburgh, PA
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
Clinical Trials Research Services, LLC
2123
mi
from 91732
Pittsburgh, PA
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
Mainline Gastroenterology Associates
mi
from 91732
Souderton, PA
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
Mainline Gastroenterology Associates
mi
from 91732
Souderton, PA
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
ClinSearch, LLC
1862
mi
from 91732
Chattanooga, TN
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
ClinSearch, LLC
1862
mi
from 91732
Chattanooga, TN
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
Memphis Gastroenterology Group
1600
mi
from 91732
Germantown, TN
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
Memphis Gastroenterology Group
1600
mi
from 91732
Germantown, TN
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
KRK Medical Research
1223
mi
from 91732
Dallas, TX
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
KRK Medical Research
1223
mi
from 91732
Dallas, TX
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
Research Across America
1214
mi
from 91732
Dallas, TX
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
Research Across America
1214
mi
from 91732
Dallas, TX
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
Pioneer Research Solutions, Inc.
1355
mi
from 91732
Houston, TX
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
Pioneer Research Solutions, Inc.
1355
mi
from 91732
Houston, TX
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
Pioneer Research Solutions
1347
mi
from 91732
Sugar Land, TX
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
Pioneer Research Solutions
1347
mi
from 91732
Sugar Land, TX
Click here to add this to my saved trials